Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FUXZW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,820
Award facts
- Contract value 100% obligated
- $5,819.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,819.64 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide.
Repatha (evolocumab) is a PCSK9 inhibitor used for managing high cholesterol in patients with cardiovascular disease, representing a specialty pharmaceutical product within the company's broader portfolio of brand-name medications supplied to the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's extensive contract activity with DLA demonstrates its capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging from minimal to substantial values and encompassing diverse therapeutic domains including specialty medications, generics, vaccines, and medical devices supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FUXZW?
SPE2DB25FUXZW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FUXZW worth?
The government has obligated $5,820 on SPE2DB25FUXZW.
Is contract SPE2DB25FUXZW an order under another contract?
Yes. SPE2DB25FUXZW is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUXZW competed?
The extent of competition for SPE2DB25FUXZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award